Results 221 to 230 of about 119,881 (373)

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

British Journal of Haematology, Volume 208, Issue 1, Page 250-258, January 2026.
The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen‐Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour   +20 more
wiley   +1 more source

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis. [PDF]

Front Pharmacol
Bica AM, Marcu AD, Jercan CG, Iordan I, Serbanica AN, Avramescu I, Colita M, Popa DC, Constantinescu I, Ichim AM, Colita A, Colita A.   +11 more
europepmc   +1 more source

Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells [PDF]

, 2019
Chen, Yi-Bin, DiPersio, John F., et al,
core   +1 more source

Case Report: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency. [PDF]

Front Immunol
Jiang C, Sun T, Xu X, Xu W, You K.
europepmc   +1 more source

Serial Clinical and Biomarker Monitoring during Treatment Can Stratify Patients with Low Risk Gvhd [PDF]

Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vášová, Francis Ayuk, Hannah Choe, William J. Hogan, Zachariah DeFilipp, Muna Qayed, Aaron Etra, Karamjeet Sandhu, Sabrina Kraus, Timothy S. Olson, Elizabeth O. Hexner, Paibel Aguayo‐Hiraldo, Ran Reshef, Evelyn Ullrich, Tal Schechter‐Finkelstein, Carrie L. Kitko, Chantiya Chanswangphuwana, Pietro Merli, Yu Akahoshi, Janna Baez, Gilbert Eng, Rahnuma Beheshti, Steven Kowalyk, George Morales, Ioannis Louloudis, Rachel Young, Ernst Holler, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine   +32 more
openalex   +1 more source

Sirolimus and tacrolimus binding proteins: double-edged swords for GVHD prophylaxis [PDF]

, 2003
Hans‐Peter Kiem, Claudio Anasetti
openalex   +1 more source

Toll‐Like Receptor Polymorphisms Influence Graft‐Versus‐Host Disease and Infection Risk After Single‐Unit Cord Blood Transplantation for Adults

European Journal of Haematology, Volume 116, Issue 1, Page 37-45, January 2026.
ABSTRACT Background Toll‐like receptors (TLRs) play a critical role in innate immunity by recognizing pathogen‐associated and damage‐associated molecular patterns. Genetic polymorphisms in TLR genes can modulate immune responses and have been implicated in the outcomes of allogeneic hematopoietic cell transplantation (HCT).
Takaaki Konuma, Megumi Hamatani‐Asakura, Seiko Kato, Shohei Andoh, Hirona Ichimura, Junichi Kuroda, Kaori Kondo, Kazuaki Yokoyama, Maki Monna‐Oiwa, Yasuhito Nannya, Satoshi Takahashi   +10 more
wiley   +1 more source

Prophylactic donor lymphocyte infusions after first allogeneic hematopoietic stem cell transplantation in children with acute leukemia. [PDF]

Blood Res
Wei A, Jia C, Zhu G, Yang J, Zheng J, Jing Y, Zhang M, Cai L, Han Y, Sun X, Shu C, Chen W, Qin M, Wang B, Luo Y.   +14 more
europepmc   +1 more source

Amphiregulin modifies the Minnesota acute graft-versus-host disease risk score: Results from BMT CTN 0302/0802 [PDF]

, 2018
Pusic, Iskra
core   +1 more source

Advances in the clinical management of GVHD

, 2008
James L.M. Ferrara
openalex   +1 more source